Cyclic and dimeric gluten peptide analogues inhibiting DQ2-mediated antigen presentation in celiac disease.
about
Type 1 diabetes mellitus and gluten induced disordersTherapeutic approaches for celiac diseaseCoeliac disease and gluten-related disorders in childhoodCeliac disease and pediatric type 1 diabetes: diagnostic and treatment dilemmas.Novel therapies for coeliac diseaseReview article: coeliac disease, new approaches to therapy.Modeling of celiac disease immune response and the therapeutic effect of potential drugsPhenotypical characterization of the peripheral blood T cells in patients with celiac disease: does it differentiate suspicious celiac disease cases?Resolving multiple protein-peptide binding events: implication for HLA-DQ2 mediated antigen presentation in celiac disease.Investigational therapies for celiac disease.Coeliac disease--a diagnostic and therapeutic challenge.Peptidomimetics: modifying peptides in the pursuit of better vaccines.New clues in celiac disease epidemiology, pathogenesis, clinical manifestations, and treatment.Experiences with animal models of dermatitis herpetiformis: a review.In vitro models for gluten toxicity: relevance for celiac disease pathogenesis and development of novel treatment options.Future treatment strategies for celiac disease.Recent advances in the development of new treatments for celiac disease.Advances in the treatment of coeliac disease: an immunopathogenic perspective.Celiac disease: the search for adjunctive or alternative therapies.Current status of drugs in development for celiac disease.Taming the TCR: antigen-specific immunotherapeutic agents for autoimmune diseases.Physiopathology and Management of Gluten-Induced Celiac Disease.The roles of MHC class II genes and post-translational modification in celiac disease.Enzymatic detoxification of gluten by germinating wheat proteases: implications for new treatment of celiac disease.Cyclodimerization of immunosuppressive fragment of HLA-DR molecule. Design, synthesis and ESI-MS/MS analysis.
P2860
Q24562995-C1B9DFA1-FA3C-4FF6-81EF-BD1A68FCFCDFQ26825413-5B23E20F-DA22-4F78-8BED-E7D59E5932FFQ28263872-0E2B0C7A-C79F-4B17-ADBC-861ADE477A0EQ34002003-8C52901D-71AB-448A-8F08-7D3D944414C5Q34170574-9A55DCEB-B02C-4392-9AC2-9C1B06448CA4Q34253519-FC9CD04C-44E1-4EDC-A054-4C9F117968F4Q34798574-CF25E3FC-24C3-4063-8B6C-E50646AE32A3Q35483584-03C315F4-D889-4ECD-BB37-6A68B258490EQ36055610-73FBB7B8-F6EC-4996-B01D-34AFD3E17E0EQ37638684-D0264258-124E-44E4-9311-46C4AE71180EQ37767725-8A62FC32-4299-44C5-BD17-B13034B1D5BFQ37844539-B80602CA-A5BD-47BF-8AE0-32F7FC2250C2Q37905046-5D7DDB1C-FE40-4C60-8DBF-7E05234F6E92Q37934991-0D3F107E-C6B6-4311-9CC7-80D07423C94BQ37979161-684860FE-A9DD-4019-AF50-F422CA6447D9Q38012460-BAF21B6B-8DB1-45B1-966B-F9C2FA1BAA07Q38038684-83004DEA-1CA0-48B0-BFA2-E5D608597D4DQ38126789-6DD8C598-6930-4EBA-BB3E-3592B9393FFFQ38184586-CB1E4618-E9A8-4D1C-B61F-1B27654DB7D5Q38210088-DD781FD1-24FA-4F20-BE5E-632D11A4801EQ38477340-F3D0443D-0F17-4C68-9911-7AD889BE6181Q39111493-B97DBA22-8DA6-4762-A162-18AB3597DD9FQ39427548-D8B385E0-388A-4B6C-9C60-565D471C8424Q46057460-313DC2AE-7564-4C70-A37E-B0FBD7C10E04Q51626103-3AE73675-02DD-4884-8FDB-13466F75ACF8
P2860
Cyclic and dimeric gluten peptide analogues inhibiting DQ2-mediated antigen presentation in celiac disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Cyclic and dimeric gluten pept ...... resentation in celiac disease.
@ast
Cyclic and dimeric gluten pept ...... resentation in celiac disease.
@en
type
label
Cyclic and dimeric gluten pept ...... resentation in celiac disease.
@ast
Cyclic and dimeric gluten pept ...... resentation in celiac disease.
@en
prefLabel
Cyclic and dimeric gluten pept ...... resentation in celiac disease.
@ast
Cyclic and dimeric gluten pept ...... resentation in celiac disease.
@en
P2093
P2860
P1476
Cyclic and dimeric gluten pept ...... presentation in celiac disease
@en
P2093
Burkhard Fleckenstein
Chaitan Khosla
Elin Bergseng
Ludvig M Sollid
Matthew Siegel
P2860
P304
P356
10.1016/J.BMC.2007.07.001
P407
P577
2007-07-25T00:00:00Z